224 related articles for article (PubMed ID: 20536364)
1. Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin.
Nouira S; Marghli S; Besbes L; Boukef R; Daami M; Nciri N; Elatrous S; Abroug F
Clin Infect Dis; 2010 Jul; 51(2):143-9. PubMed ID: 20536364
[TBL] [Abstract][Full Text] [Related]
2. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.
Talan DA; Stamm WE; Hooton TM; Moran GJ; Burke T; Iravani A; Reuning-Scherer J; Church DA
JAMA; 2000 Mar 22-29; 283(12):1583-90. PubMed ID: 10735395
[TBL] [Abstract][Full Text] [Related]
3. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation requiring mechanical ventilation: a randomised placebo-controlled trial.
Nouira S; Marghli S; Belghith M; Besbes L; Elatrous S; Abroug F
Lancet; 2001 Dec; 358(9298):2020-5. PubMed ID: 11755608
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
McCarty JM; Richard G; Huck W; Tucker RM; Tosiello RL; Shan M; Heyd A; Echols RM
Am J Med; 1999 Mar; 106(3):292-9. PubMed ID: 10190377
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.
Alía I; de la Cal MA; Esteban A; Abella A; Ferrer R; Molina FJ; Torres A; Gordo F; Elizalde JJ; de Pablo R; Huete A; Anzueto A
Arch Intern Med; 2011 Nov; 171(21):1939-46. PubMed ID: 22123804
[TBL] [Abstract][Full Text] [Related]
6. Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
Faisy C; Meziani F; Planquette B; Clavel M; Gacouin A; Bornstain C; Schneider F; Duguet A; Gibot S; Lerolle N; Ricard JD; Sanchez O; Djibre M; Ricome JL; Rabbat A; Heming N; Urien S; Esvan M; Katsahian S;
JAMA; 2016 Feb; 315(5):480-8. PubMed ID: 26836730
[TBL] [Abstract][Full Text] [Related]
7. Reduced antibiotic pressure for the treatment of acute exacerbation of chronic obstructive pulmonary disease: back to the future.
Fantin B
Clin Infect Dis; 2010 Jul; 51(2):150-2. PubMed ID: 20536365
[No Abstract] [Full Text] [Related]
8. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
10. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial.
Verdier RI; Fitzgerald DW; Johnson WD; Pape JW
Ann Intern Med; 2000 Jun; 132(11):885-8. PubMed ID: 10836915
[TBL] [Abstract][Full Text] [Related]
11. Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection: A Randomized Clinical Trial.
Drekonja DM; Trautner B; Amundson C; Kuskowski M; Johnson JR
JAMA; 2021 Jul; 326(4):324-331. PubMed ID: 34313686
[TBL] [Abstract][Full Text] [Related]
12. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
Rothberg MB; Pekow PS; Lahti M; Brody O; Skiest DJ; Lindenauer PK
JAMA; 2010 May; 303(20):2035-42. PubMed ID: 20501925
[TBL] [Abstract][Full Text] [Related]
14. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.
Lew MA; Kehoe K; Ritz J; Antman KH; Nadler L; Kalish LA; Finberg R
J Clin Oncol; 1995 Jan; 13(1):239-50. PubMed ID: 7799026
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial.
Sánchez C; García-Restoy E; Garau J; Bella F; Freixas N; Simó M; Lite J; Sánchez P; Espejo E; Cobo E
J Infect Dis; 1993 Nov; 168(5):1304-7. PubMed ID: 8228368
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess.
Talan DA; Mower WR; Krishnadasan A; Abrahamian FM; Lovecchio F; Karras DJ; Steele MT; Rothman RE; Hoagland R; Moran GJ
N Engl J Med; 2016 Mar; 374(9):823-32. PubMed ID: 26962903
[TBL] [Abstract][Full Text] [Related]
17. Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial.
Moran GJ; Krishnadasan A; Mower WR; Abrahamian FM; LoVecchio F; Steele MT; Rothman RE; Karras DJ; Hoagland R; Pettibone S; Talan DA
JAMA; 2017 May; 317(20):2088-2096. PubMed ID: 28535235
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on health care utilization and hospital outcomes of severe acute exacerbation of chronic obstructive pulmonary disease managed by pulmonologists vs internists.
Pothirat C; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
Int J Chron Obstruct Pulmon Dis; 2015; 10():759-66. PubMed ID: 25926727
[TBL] [Abstract][Full Text] [Related]
19. Ciprofloxacin versus trimethoprim-sulfamethoxazole: treatment of community-acquired urinary tract infections in a prospective, controlled, double-blind comparison.
Grubbs NC; Schultz HJ; Henry NK; Ilstrup DM; Muller SM; Wilson WR
Mayo Clin Proc; 1992 Dec; 67(12):1163-8. PubMed ID: 1469927
[TBL] [Abstract][Full Text] [Related]
20. Pyelonephritis treatment in the community emergency department: Cephalosporins vs. first-line agents.
Vogler S; Pavich E
Am J Emerg Med; 2018 Nov; 36(11):2054-2057. PubMed ID: 30119986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
